首页 | 本学科首页   官方微博 | 高级检索  
     

甲状腺滤泡癌组织中PD-L1与dMMR相关蛋白表达的关系及其临床意义
引用本文:邱燕如,戴毅君,江振健,林建光,曾一丹,许天文. 甲状腺滤泡癌组织中PD-L1与dMMR相关蛋白表达的关系及其临床意义[J]. 中国肿瘤生物治疗杂志, 2021, 28(3): 269-274
作者姓名:邱燕如  戴毅君  江振健  林建光  曾一丹  许天文
作者单位:福建医科大学附属第二医院 a.肿瘤内科;b.内分泌科,福建 泉州 362000
基金项目:福建省卫计委创新课题(No.2017-CXB-10);泉州科技局高层次人才科研经费资助(No.2018C051R)
摘    要:目的:探讨甲状腺滤泡癌组织中PD-L1与dMMR相关蛋白表达的关系及其临床意义.方法:收集2015年1月至2020年6月福建医科大学附属第二医院60例甲状腺滤泡癌患者的癌组织蜡块,再次经H-E染色确诊,采用免疫组化法检测癌组织和癌旁组织中PD-Ll的表达以及MMR系统4个基因(MLH1、MSH2、MSH6、PMS2)编...

关 键 词:甲状腺滤泡癌  程序性死亡配体1  错配修复功能缺陷  侵袭  复发  预后
收稿时间:2021-01-10
修稿时间:2021-03-05

Correlation between the expression of PD-L1 and dMMR related proteins in follicular thyroid carcinoma tissues and its clinical significance
QIU Yanru,DAI Yijun,JIANG Zhenjian,LIN Jianguang,ZENG Yidan,XU Tianwen. Correlation between the expression of PD-L1 and dMMR related proteins in follicular thyroid carcinoma tissues and its clinical significance[J]. Chinses Journal of Cancer Biotherapy, 2021, 28(3): 269-274
Authors:QIU Yanru  DAI Yijun  JIANG Zhenjian  LIN Jianguang  ZENG Yidan  XU Tianwen
Affiliation:a. Department of Oncology, b. Department of Endocrinology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, Fujian, China
Abstract:Objective: To investigate the correlation between PD-L1 expression and dMMR related proteins in follicular thyroid carcinoma tissues and its clinical significance. Methods: The postoperative paraffin-embedded tissue samples from 60 patients with thyroid follicular carcinoma were collected from the Second Affiliated Hospital of Fujian Medical University during January 2015 and June 2020. The collected samples were re-confirmed as thyroid follicular carcinoma tissues by Hematoxylin-eosin staining. The expression of PD-L1 and four homologous proteins encoded by four genes (MLH1, MSH2, MSH6, PMS2) in MMR system were detected by immunohistochemistry in the cancer and paracancerous tissues. The relationship between the expression of PD-L1 and depletion of MMR related proteins in thyroid follicular carcinoma tissues and its clinical significance were analyzed. Results: The positive expression rate of PD-L1 was significantly higher in the follicular thyroid carcinoma tissues than that in paracancerous tissues [63.3%(38/60) vs 11.7%(7/60), P<0.05]. The expression of PD-L1 was significantly correlated with tumor diameter, extrathyroidal infiltration, vascular invasion and recurrence (all P<0.05). In the cancer tissue specimens from 60 patients, 24 (40.0%) had expression of four MMR related proteins, which were pMMR tumors, and 36 (60.0%) had depletion of one or more MMR related proteins, which were dMMR tumors. The dMMR-type thyroid follicular carcinoma was significantly correlated with the status of lymph node metastasis and tumor staging (all P<0.05). PD-L1 was positively correlated with the incidence of dMMR, and PD-L1 was an independent risk factor for disease recurrence, while dMMR was associated with a better prognosis. Patients with PD-L1+/pMMR type were associated with higher tumor malignancy, while patients with PD-L1+/dMMR type were not associated with tumor pathological features but may easily benefit from immunotherapy. Conclusion: Positive PD-L1 expression and dMMR highly occur in follicular thyroid carcinoma. PD-L1 is associated with the increased tumor invasion and is an independent risk factor for disease recurrence,while dMMR is an early molecular event in the development of thyroid follicular carcinoma and is associated with better prognosis of patients.
Keywords:follicular thyroid carcinoma   programmed death-ligand 1(PD-L1)   defective DNA mismatch repair (dMMR)   invasion  recurrence   prognosis
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号